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 Chapter 10 
 Effi cacy of Calcium Phosphate-Based 
Scaffold Materials on Mineralized and 
Non- mineralized Tissue Regeneration 
 Osamu  Suzuki ,  Takahisa  Anada , and  Yukari  Shiwaku 
 Abstract  Calcium phosphate materials have been advocated as useful implantable 
scaffolds for bone tissue engineering. We have reported that synthetic octacalcium 
phosphate (OCP) is capable of enhancing differentiation of hard tissue-forming 
cells including osteoblastic cells, osteoclast precursor cells, and odontoblastic cells. 
The differentiation of mesenchymal stem cells is promoted to form new bone in the 
presence of OCP with atelo-collagen in vivo condition. The stimulatory capacity of 
OCP to conduct new bone increases with the copresence of amorphous calcium 
phosphate (ACP). Physical and chemical analyses of the materials suggested that 
the bioactivity of such hydroxyapatite (HA) precursor phases is induced as a result 
of the progressive change of chemical property of these materials during the hydro-
lysis into HA under physiological environment. The composite materials composed 
of OCP and natural polymers are capable of repairing not only mineralized tissues 
but also non-mineralized tissue. The form of OCP-based materials and the tissue 
responses to the materials will be summarized. 
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10.1  Introduction 
 Calcium phosphate ceramics, such as sintered hydroxyapatite (HA, Ca 10 (PO 4 ) 6 (OH) 2 ) 
and β-tricalcium phosphate (β-TCP, β-Ca 3 (PO 4 ) 2 ), have widely been used as fi lling 
materials for various bone defects due to the superior osteoconductivity which is 
capable of bonding to bone tissue without intervention of connective tissues [ 1 ]. HA 
and β-TCP have been used as implantable scaffold materials with mesenchymal 
stem cells (MSCs) for bone regeneration [ 2 ]. These calcium phosphate materials 
provide suitable site where osteoblastic cells can attach, proliferate, and differenti-
ate [ 2 ]. The physicochemical property of calcium phosphate materials affects 
the cellular responses to some extent [ 3 ,  4 ]. Octacalcium phosphate (OCP, 
Ca 8 H 2 (PO 4 ) 6 ·5H 2 O) is a non-sintered calcium phosphate material which was fi rst 
proven to directly bond to bone tissue by onlaying it on mouse calvaria [ 5 ]. OCP has 
been regarded as a precursor phase in HA formation from supersaturated calcium 
and phosphate solutions with respect to HA and is therefore suggested to be a pre-
cursor to bone apatite crystals [ 6 ,  7 ] as well as amorphous calcium phosphate (ACP, 
Ca 3 (PO 4 ) 2 ·nH 2 O) [ 8 ]. OCP shows diversity regarding the stoichiometry [ 9 ] and the 
microstructure [ 10 ] depending on the preparation condition [ 11 ], which controls its 
bioactivity in vitro and in vivo [ 11 ]. This article summarizes the bioactivity of OCP 
and the composite materials with natural polymers as scaffold materials we have 
reported previously. 
10.2  Mineralized and Non-mineralized Tissue Responses 
 OCP displays a unique osteoconductive property which tends to biodegrade and be 
followed by new bone formation if implanted in various bone defects, including the 
defects in intramembranous bone and long bones in various animal models [ 11 ,  12 ]. 
The effi cacy of OCP has recently been reported by implanting its composite with 
collagen in human maxilla after cystectomy [ 13 ]. The stimulatory capacity of OCP 
could be induced by the environmental changes around the crystals, including cal-
cium ion concentration change, due to the progressive hydrolysis from OCP to HA 
under physiological conditions [ 5 ,  14 ,  15 ]. The hydrolysis of OCP to HA is enhanced 
if ACP coexists with OCP, and the bone regenerative capacity of OCP is augmented 
by mechanically mixing OCP with ACP in rat critical-sized calvaria defect [ 16 ]. A 
composite of OCP with gelatin matrix, prepared through a wet synthesis, showed a 
greater biodegradable property coupled with a greater bone regenerative property if 
the material was implanted in rat critical-sized calvaria defect [ 17 ,  18 ]. The in vivo 
studies indicated that OCP/gelatin composite repairs not only rabbit tibia defect 
model [ 19 ] but also reforms infraspinatus tendon insertion using rabbit rotator cuff 
tear model [ 20 ]. 
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10.3  Matrix Materials for Calcium Phosphate 
 Various calcium phosphate composites with natural polymers have been developed 
for bone and other tissue engineering (Table  10.1 ). Collagen (Col) is the major com-
ponent of extracellular matrix proteins in bone, and its reconstituted Col has been 
utilized as matrix materials for calcium phosphates. HA/Col composites have been 
prepared by different processes, such as direct physical mixing [ 21 ,  22 ], chemical 
deposition of HA [ 23 ], or biomimetic mineralization [ 24 ]. Biodegradable calcium 
 Table 10.1  Calcium phosphate composites with various natural polymers designed for bone 
tissue engineering 
 Natural polymers 
 Calcium 
phosphates  Composites  Notes (references) 
 Collagen  HA  Sponge  Chemical deposition [ 23 ] 
 Nano HA  Sponge  Physical mixture [ 22 ] 
 Nanofi ber  Physical mixture [ 21 ] 
 Fiber  Biomimetic mineralization [ 24 ] 
 OCP  Sponge  Chemical deposition [ 26 ] 
 β-TCP  Sponge  Physical mixture [ 25 ] 
 Gelatin  HA  Particles  Chemical deposition [ 29 ] 
 Sponge  Chemical deposition [ 30 ] 
 Porogen leaching [ 31 ] 
 Film  Physical mixture [ 28 ] 
 OCP  Sponge  Chemical deposition [ 17 ] 
 Chemical deposition and physical 
mixture [ 18 ] 
 β-TCP  Sponge  Physical mixture [ 49 ] 
 Chitosan  HA  Sponge  Biomimetic mineralization [ 36 ] 
 Nano HA  Sponge  Physical mixture [ 35 ] 
 Chemical deposition [ 33 ] 
 β-TCP  Sponge  Physical mixture [ 37 ] 
 Silk fi broin  HA  Sponge  Physical mixture [ 34 ] 
 Film  Biomimetic mineralization [ 50 ] 
 Ca-defi cient HA  Particles  Chemical deposition [ 32 ] 
 Alginate  HA  Sponge  Physical mixture [ 40 ] 
 Biomimetic mineralization [ 39 ] 
 Beads  Chemical deposition [ 41 ] 
 OCP  Sponge  Chemical deposition [ 42 ] 
 Physical mixture [ 43 ] 
 Beads  Physical mixture [ 45 ] 
 β-TCP  Beads  Physical mixture [ 38 ] 
 Hyaluronic acid  HA  Hydrogel  Physical mixture [ 46 ] 
 OCP  Hydrogel  Physical mixture [ 48 ] 
 β-TCP  Hydrogel  Physical mixture [ 47 ] 
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phosphates/Col composites, such as OCP/Col and β-TCP/Col, have also been 
obtained using coprecipitation methods [ 25 ,  26 ] and by physical mixing [ 27 ]. 
Gelatin (Gel) is a denatured form of collagen and has the advantage of higher bio-
degradability. HA/Gel composites have been obtained in various forms, not only in 
porous form but also in fi lm and particle forms [ 28 – 31 ]. OCP/Gel composites have 
been prepared by physical mixing and coprecipitation [ 17 ,  18 ]. Other natural poly-
mers, such as chitosan and silk fi broin, have also been combined with calcium phos-
phates [ 32 – 37 ].
 Alginate (Alg) is a natural polysaccharide obtained from brown algae and applied 
for wound healing and drug delivery due to its biocompatibility. HA/Alg and β-TCP/
Alg have been prepared as porous scaffolds or beads [ 38 – 41 ]. Our group has devel-
oped OCP/Alg porous scaffolds [ 42 ,  43 ]. Although it is known that Alg is not able 
to interact with mammalian cells [ 44 ], OCP/Alg was capable of enhancing osteo-
blastic cell attachment and bone formation depending on the pore size and the 
porosity of the composites [ 42 ]. OCP/Alg beads including osteoblastic cells have a 
potential to activate and deliver osteoblastic cells from the beads to the local sites of 
bone defects [ 45 ]. Hyaluronic acid (HyA) is a major component of the extracellular 
matrix in the connective tissue. HyA hydrogel can be used as injectable materials 
fi lling bone defects directly and has been reported to promote bone regeneration 
[ 46 ,  47 ]. OCP/HyA is a bone substitute material which was proven to show the 
injectable and bioactive properties [ 48 ]. 
10.4  Cell Responses to Calcium Phosphate Materials 
 We have reported that OCP induces osteoblastic differentiation of mouse stromal 
cells [ 15 ,  51 ]. When mouse ST2 cells were cultured on the OCP or HA coatings, 
expression of osteogenic markers, such as type I collagen, alkaline phosphatase, and 
osterix, was enhanced on the OCP coating plates in an OCP dose-dependent manner 
[ 51 ]. We also reported that OCP enhanced alkaline phosphatase (ALP) activity of 
mouse mesenchymal stem cell line D1 cells in a three-dimensional cell culture sys-
tem compared to HA and β-TCP [ 52 ]. When rat dental pulp cells were cultured on 
the OCP or HA coatings, OCP promoted their odontoblastic differentiation more 
than HA, as confi rmed by ALP activity, mineralization, and enhancement of dentine 
sialophosphoprotein expression [ 53 ]. Furthermore, OCP is capable of inducing 
osteoclast formation from bone marrow cells in vitro in the presence of osteoblasts 
without vitamin D 3 [ 54 ]. 
 OCP can gradually convert into the crystal structure of apatite in the physiologi-
cal conditions [ 11 ]. The conversion induces the release of phosphate ions to the 
periphery of the crystals and the uptake of calcium ion into the crystals [ 14 ]. We 
demonstrated that these changes in ion concentration have effects on osteoblastic 
differentiation through the phosphorylation of p38 MAP kinase [ 55 ], migration of 
macrophage-like cells [ 56 ], and osteoclastic differentiation by the increase of the 
expression of RANKL in osteoblasts [ 54 ]. 
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10.5  Conclusion 
 We have designed OCP-based materials and reported their tissue regenerative prop-
erties not only in the calcifi ed tissues but also in the noncalcifi ed tissue. The physi-
cochemical properties of OCP induced in the conversion process from OCP to HA 
could be involved in promoting osteoblastic and osteoclastic differentiation and 
bone formation and reformation of infraspinatus tendon insertion. The composite 
materials of OCP with natural polymers, described in this article, could be used as 
scaffold materials for mineralized tissue regeneration and potentially for non- 
mineralized tissue regeneration. 
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